[Chagas disease and immunosuppression].
D000328:Adult; D000368:Aged; D000970:Antineoplastic Agents / Q000627:therapeutic use; D014355:Chagas Disease / Q000150:complications / Q000188:drug therapy / Q000276:immunology*; D002908:Chronic Disease; D005260:Female; D006801:Humans; D007165:Immunosuppression Therapy / Q000009:adverse effects; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D008180:Lupus Erythematosus, Systemic / Q000150:complications / Q000188:drug therapy; D008297:Male; D008875:Middle Aged; D009369:Neoplasms / Q000150:complications / Q000188:drug therapy; D009547:Nifurtimox / Q000627:therapeutic use; D011241:Prednisone / Q000627:therapeutic use
D000970:Antineoplastic Agents; D007166:Immunosuppressive Agents; D009547:Nifurtimox; D011241:Prednisone
Enfermedad de Chagas e inmunosupresión.